Mode Sensors secures FDA 510(k) market clearance for the Re:Balans wearable device for fluid monitoring

We're testing our Re:Balans wearable at Solfjellshøgda Health Center. Right now, healthcare staff are using our solution to monitor and follow up on hydration levels for residents. The wave of interest from healthcare institutions nationally and internationally shows we're onto something big!

Mode Sensors Receives RFF Grant for Clinical Validation of Re:Balans hydration monitoring

Mode Sensors (MODE) is pleased to announce the initiation of a new clinical trial at Solfjellhøgda Rehabilitation Centre, focusing on the...

Mode Sensors (MODE) is proud to announce that its Re:Balans hydration wearable tracking technology has been featured in a peer-reviewed...

Hydration monitoring may play a critical role in mission success and safety in military aviation. Mode Sensors (MODE) has signed a $1.78 million contract with Lockheed Martin to test and co-develop advanced wearable hydration monitoring technology for cockpit environments. The partnership includes financial investment, knowledge transfer, and engineering collaboration from Lockheed Martin.  Enhancing Pilot Safety and Performance Hydration plays a critical role in mission succ

Mode Sensors (MODE) is proud to announce the granting of a patent for its innovative hydration monitoring technology in Norway under...

Re:Balans Hydration Monitoring Technology Featured in Peer-Reviewed Journal Mode Sensors (MODE) is pleased to announce that its...

Mode Sensors (MODE) is proud to announce its certification under ISO 13485, the internationally recognized standard for quality...

Mode Sensors (MODE) is pleased to announce a collaboration agreement with a leading U.S. medical device manufacturer to test Re:Balans...

Mode Sensors is granted 2,5 million euros from the EU's 2020 Horizon Program, with an additional 2 million euro "blended-finance"...